Increased EZH2 expression in tumorous versus corresponding normal tissue has been also reported for other cancers as well, including malignant melanoma, prostate carcinoma, breast cancer and hepatocellular carcinoma [7,9,17,37]. The gene discussed is EZH2; the disease is melanoma.